MOGAT1: A Potential Drug Target and Biomarker for Diseases (G116255)

Target Name: MOGAT1

NCBI ID: G116255

MOGAT1

MOGAT1: A Potential Drug Target and Biomarker for Diseases

MOGAT1 (DGAT2L1) is a gene that has been identified as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MOGAT1 is a non-coding RNA molecule that is expressed in a variety of tissues and cells in the body. It is part of the MOGAT1 gene family, which is known for its role in regulating mitochondrial function and energy metabolism.

One of the things that makes MOGAT1 an attractive drug target is its involvement in a wide range of cellular processes that are important for human health and disease. For example, MOGAT1 has been shown to play a role in the development and progression of cancer, including breast, ovarian, and prostate cancers. It has also been linked to a number of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases, as well as autoimmune disorders such as rheumatoid arthritis and multiple sclerosis.

In addition to its involvement in disease, MOGAT1 is also a potential biomarker for several diseases. For example, it has been shown to be elevated in the blood of people with breast cancer, and may be a useful diagnostic marker for this disease. It has also been shown to be elevated in the urine of people with Alzheimer's disease, which may make it a useful diagnostic tool for this disease as well.

Another promising aspect of MOGAT1 is its potential to be a drug target. Research has shown that MOGAT1 can be inhibited using small molecules, which could make it an attractive target for drug development. Additionally, MOGAT1 has been shown to interact with several different signaling pathways, including TGF-β and NF-kappa-B, which could make it a good candidate for inhibitors that target these pathways.

In conclusion, MOGAT1 is a gene that has the potential to be a drug target or biomarker for a wide range of diseases. Its involvement in cellular processes that are important for human health and disease, as well as its potential as a biomarker, make it an attractive target for drug development. Further research is needed to fully understand the role of MOGAT1 in disease and to develop effective treatments.

Protein Name: Monoacylglycerol O-acyltransferase 1

Functions: Catalyzes the formation of diacylglycerol from 2-monoacylglycerol and fatty acyl-CoA. Probably not involved in absorption of dietary fat in the small intestine

The "MOGAT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MOGAT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets